A bill that would allow for the medical use of psilocybin, the hallucinogenic ingredient in magic mushrooms, has been filed in the Montana Legislature.
House Bill 955 was officially introduced in the House of Representatives yesterday. The proposed law would allow those with post traumatic stress disorder (PTSD), an anxiety or depressive disorder or a substance use disorder to legally use psilocybin for medical and therapeutic purposes.
According to its official legal review note, as drafted “allows the therapeutic use of psilocybin for certain mental health conditions at therapeutic psilocybin treatment centers, establishes requirements for certifying a person to use therapeutic psilocybin, establishes requirements for licenses to administer psilocybin, and allows cultivation, manufacture, packages, labelling, possession, and administration of psilocybin at licensed therapeutic psilocybin treatment centers.”
Continue reading
Senate Bill 346 was filed by Senator Graig Meyer with six cosponsors. The measure would legalize, for those 21 and older, the possession of up to two ounces of dried marijuana, up to 15 grams of marijuana concentrates (hash, oil, etc.) and up to 2,000 mg in THC worth of edibles. The proposal would also allow for the personal cultivation of up to six plants.
The committee approved Senate Bill 516 by a vote of 7 to 2, moving it towards a vote by the full Senate. A version of the bill has already passed the House of Representatives, but will need to go back (or a conference committee established) if it’s passed by the full Senate in order to concur with or make changes to committee-approved amendments.
House Bill 1053, “An Act to prohibit the issuance of a written certification to a pregnant woman or breastfeeding mother for purposes of medical cannabis use”, was filed by State Representative Fred Deutsh along with 15 cosponsors, all Republican.
House Bill 1 and House Bill 2, both filed by State Representative Ed Osienksi in the House and sponsored by Senator Trey Paradee in the Senate, are scheduled for votes in the Delaware Senate on Tuesday, March 28. House Bill 2
“Previous research indicated that cannabidiol (CBD) may result in low levels of male total testosterone (TT), elevations in liver tests (LTs), and daytime drowsiness (DD)”, states the study’s abstract. “We investigated the prevalences of TT and LT in a large adult sample self-administering CBD and determined the effect self-dosing of CBD has on the severity of DD.”
“With other social media platforms censoring cannabis posts and content, it was time to build our own community that is inclusive for all cannabis enthusiasts and content without the fear of unwanted and improper censorship,” says CEO Jonathan Black.
Oregon sold a total of $148,366,891 million between January 1 and February 28 this year, with sales data not yet available for any part of March. This is according to data released by the Oregon Liquor and Cannabis Commission. Based on the state’s 17% marijuana tax rate, the state garnered $25.2 million in marijuana taxes during this period.
In total Nevada made $649 million in taxes from the legal distribution of $3,595,065,939 worth of marijuana and marijuana products. This is according to 
The study is being published in the recent issue of the journal Neurochemical Research, and it was epublished online ahead of print by the National Library of Medicine. The research was conducted by investigators from the Universidade Federal de São Paulo, the Brazil National Institute for Translational Medicine and the University of São Paulo.
